Autologous SVF Therapy for Type 2 Diabetes
Recruiting
N/A
Interventional Study
Diabetes Mellitus, Type 2
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 10 (estimated)
- Sponsor
- Kaiser Clinic and Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective clinical study aims to evaluate the safety and efficacy of autologous adipose-derived stromal vascular fraction (SVF), enriched with mesenchymal stem cells (ADSCs), for the treatment of Type 2 Diabetes Mellitus (T2DM).
Adipose tissue will be harvested using a 1210-nm diode laser-assisted selective photochemical stimulation technique (One-STEP™ method), followed by centrifugation …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Both sexes
* Diagnosis of Type 2 Diabetes Mellitus for less than 10 years
* BMI ≥ 25 kg/m²
* HbA1c between 7.5% and 9.5%
* C-peptide \> 1.0 nmol/L
* Use of metformin and/or pioglitazone, with or without sulfonylurea
Exclusion Criteria:
* Type 1 Diabetes Mell…
Contacts